SNGX SOLIGENIX INC US FDA Inspections 8-K Filing 2023 - Other Events Soligenix, Inc. announced the outcome of a Type A Meeting with the FDA regarding their new drug application for HyBryte in the treatment of CTCL.Get access to all SEC 8-K filings of the SOLIGENIX INC